Mark Leong – Executive Chairman – Osteopore (ASX:OSX) is a Singapore-headquartered corporation poised to be a leading medical device company in the region. It is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.
Copyright 2023 – Finance News Network
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
27 Sep 2021 - PropTech Group Limited (ASX:PTG) CEO and Managing Director Joe Hanna introduces the company's suite of market-leading real estate software solutions, discussing FY21 results and outlook.
31 Aug 2022 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes discusses new opportunities for the company's automation technology.
17 Feb 2023 - Shaw and Partners Chief Investment Officer Martin Crabb discusses financial conditions, the outlook for growth, central bank monetary policy, and what this means for portfolio construction.
16 Oct 2024 - Rita Gatt, National Lead Partner - Regulation, Security and Risk at Deloitte, discusses the revolutionary potential of quantum computing.
15 Mar 2023 - Lake Resources Limited (ASX:LKE) Managing Director and CEO David Dickson discusses how he ended up at Lake, the company's focus over the last half, building a new team, Lake's technology partner Lilac Solutions, offtake agreements, credit export agencies and operational updates.
03 Nov 2023 - Vital Metals (ASX:VML) Chairman Richard Crookes shares exclusive insights on Nechalacho, Rare Earth projects, and the company's strategic partnerships, offering a compelling overview of their journey and future prospects.
10 Jul 2024 - Santana Minerals Limited (ASX:SMI) CEO Damian Spring provides an update on the company's progress, discussing an increase in indicated resource at the RAS deposit, expected completion of the prefeasibility study, stakeholder engagement, and the possible impact of the Fast-Track Approvals Bill.